Shigeharu Nakano
Kitano, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Self-Made Internal Traction Method For Endoscopic Submucosal Dissection of Early Gastric Cancer.
Journal: Journal of visualized experiments : JoVE
Published: June 22, 2026
Atezolizumab plus Bevacizumab versus Lenvatinib as First-Line Treatment for Unresectable Hepatocellular Carcinoma Stratified by the CRAFITY Score: An International Multicenter Study.
Journal: Liver cancer
Published: February 06, 2026
MSH2 prevents liver tumorigenesis by regulating cell cycle checkpoints under chronic inflammation.
Journal: Carcinogenesis
Published: October 20, 2025
Outcome and Prognostic Factors of Colorectal Endoscopic Submucosal Dissection in Patients Aged Over 75 Years.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: August 24, 2025
Lenvatinib Versus Atezolizumab Plus Bevacizumab as First-Line Treatment for Advanced Hepatocellular Carcinoma With a CRAFITY Score of 2: A Multi-Center Retrospective Study.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: June 20, 2025
A Case of Liver Hemorrhage Uncontrollable by Transarterial Embolization after Percutaneous Liver Biopsy in a Patient with Intravascular Large B-cell Lymphoma.
Journal: Interventional radiology (Higashimatsuyama-shi (Japan)
Published: March 18, 2025
Acquisition Process and Clinical Relevance of dMMR-Associated Mutational Signatures in Hepatocellular Carcinoma.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: November 17, 2024
Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.
Journal: Journal of gastroenterology
Published: October 21, 2024
CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.
Journal: Journal of gastroenterology
Published: June 05, 2024
TERT upregulation promotes cell proliferation via degradation of p21 and increases carcinogenic potential.
Journal: The Journal of pathology
Published: December 16, 2023
A Rare Case of Donor-Origin Intrahepatic Cholangiocarcinoma After Liver Transplantation for Hepatocellular Carcinoma: A Case Report.
Journal: Transplantation proceedings
Published: June 20, 2023
A simplified method to quantitatively predict the effect of lenvatinib on hepatocellular carcinoma using contrast-enhanced ultrasound with perfluorobutane microbubbles.
Journal: Quantitative imaging in medicine and surgery
Published: June 03, 2021
Last Updated: 09/26/2026